文献速递关节外科

全膝关节置换术后使用血管紧张素受体阻滞剂与麻醉下手法松解、关节镜下粘连松解及假体相关并发症发生率降低相关

Postoperative Angiotensin Receptor Blocker Use is Associated With Decreased Rates of Manipulation Under Anesthesia, Arthroscopic Lysis of Adhesions, and Prosthesis-Related Complications in Patients Undergoing Total Knee Arthroplasty.
PubMed 文献 · J Arthroplasty · 2023-10-17

这项回顾性研究基于大型全国保险数据库,分析初次全膝关节置换术后90天内服用血管紧张素受体阻滞剂(ARB)对术后1年和2年并发症的影响。在1,299,106例接受全膝关节置换术的患者中,82,065例在术后立即填写了至少90天的氯沙坦、缬沙坦或奥美沙坦处方。多因素逻辑回归显示,ARB使用与术后2年麻醉下手法松解、关节镜/粘连松解、无菌性松动、假体周围骨折和翻修的发生率降低相关。

要点

  • 全膝关节置换术后90天内使用ARB与术后2年麻醉下手法松解发生率降低相关(OR=0.94)。
  • ARB使用与术后2年关节镜/粘连松解(OR=0.86)、无菌性松动(OR=0.71)发生率降低相关。
  • ARB使用与术后2年假体周围骨折(OR=0.58)、翻修(OR=0.79)发生率降低相关。

核心结论

  • 全膝关节置换术后90天内使用ARB与麻醉下手法松解、关节镜/粘连松解、无菌性松动、假体周围骨折和翻修风险降低相关,显示ARB潜在的保护作用。

研究设计与样本

  • 回顾性研究,从大型全国保险数据库选取初次全膝关节置换术患者,评估术后ARB使用对并发症的影响。
  • 共1,299,106例患者接受全膝关节置换术,其中82,065例在术后立即填写了至少90天的氯沙坦、缬沙坦或奥美沙坦处方。
  • 采用多因素逻辑回归控制多种合并症,分析术后1年和2年麻醉下手法松解、关节镜/粘连松解、无菌性松动、假体周围骨折和翻修的发生率。

主要发现

  • 术后2年,ARB使用与麻醉下手法松解发生率降低相关(OR=0.94,95%CI 0.90至0.99)。
  • 术后2年,ARB使用与关节镜/粘连松解发生率降低相关(OR=0.86,95%CI 0.77至0.95)。
  • 术后2年,ARB使用与无菌性松动发生率降低相关(OR=0.71,95%CI 0.61至0.83)。
  • 术后2年,ARB使用与假体周围骨折发生率降低相关(OR=0.58,95%CI 0.46至0.71)。
  • 术后2年,ARB使用与翻修发生率降低相关(OR=0.79,95%CI 0.74至0.85)。

临床怎么用

  • 作者认为,全膝关节置换术后90天内使用ARB与麻醉下手法松解、关节镜/粘连松解、无菌性松动、假体周围骨折和翻修风险降低相关,显示ARB潜在的保护作用。
  • 作者建议,针对有术后僵硬风险的患者开展评估ARB使用的前瞻性研究,将有助于进一步阐明这一关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The cellular mechanisms underlying excess scar tissue formation in arthrofibrosis following total knee arthroplasty (TKA) are well-described. Angiotensin receptor blockers (ARB), particularly losartan, is a commonly prescribed antihypertensive with demonstrated antifibrotic properties. This retrospective study aimed to assess the rates of 1- and 2-year postoperative complications in patients who filled prescriptions for ARBs during the 90 days after TKA. METHODS: Patients undergoing primary TKA were selected from a large national insurance database, and the impact of ARB use after TKA on complications was assessed. Of the 1,299,106 patients who underwent TKA, 82,065 had filled at least a 90-day prescription of losartan, valsartan, or olmesartan immediately following their TKA. The rates of manipulation under anesthesia (MUA), arthroscopic lysis of adhesions (LOA), aseptic loosening, periprosthetic fracture, and revision at 1 and 2 years following TKA were analyzed using multivariable logistic regressions to control for various comorbidities. RESULTS: ARB use was associated with decreased rates of MUA (odds ratio [OR] = 0.94, 95% confidence interval (CI), 0.90 to 0.99), arthroscopy/LOA (OR = 0.86, 95% CI, 0.77 to 0.95), aseptic loosening (OR = 0.71, 95% CI, 0.61 to 0.83), periprosthetic fracture (OR = 0.58, 95% CI, 0.46 to 0.71), and revision (OR = 0.79, 95% CI, 0.74 to 0.85) 2 years after TKA. CONCLUSIONS: ARB use throughout the 90 days after TKA is associated with a decreased risk of MUA, arthroscopy/LOA, aseptic loosening, periprosthetic fracture, and revision, demonstrating the potential protective abilities of ARBs. Prospective studies evaluating the use of ARBs in patients at risk for postoperative stiffness would be beneficial to further elucidate this association.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Albright JA, Testa EJ, Ibrahim Z, et al. Postoperative Angiotensin Receptor Blocker Use is Associated With Decreased Rates of Manipulation Under Anesthesia, Arthroscopic Lysis of Adhesions, and Prosthesis-Related Complications in Patients Undergoing Total Knee Arthroplasty. J Arthroplasty. 2023. PMID: 37852448. doi:10.1016/j.arth.2023.10.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。